DARA SCHWARTZ: Open Payments
NPI 1134610959 · PORT SAINT LUCIE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,895 in 89 payments from 20 companies in 2025. Trend: 2023 $32 · 2024 $1,292 · 2025 $1,895
Food & beverage: $1,796Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $390 |
| Insmed, Inc. | 20 | $377 |
| GlaxoSmithKline, LLC. | 12 | $213 |
| Actelion Pharmaceuticals US, Inc. | 4 | $170 |
| Verona Pharma, Inc. | 4 | $94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $91 |
| Pulmonx Corporation | 4 | $69 |
| Amgen Inc. | 3 | $63 |
| Merck Sharp & Dohme LLC | 3 | $60 |
| Vifor Pharma, Inc. | 2 | $59 |
Products named: Arikayce, FASENRA, OPSUMIT, TEZSPIRE, NUCALA, TRELEGY ELLIPTA, Ohtuvayre, CHARTIS CATHETER.
Industry payments across FL — which companies pay providers there.
